New patent for Incyte Corp drug OPZELURA

February 10, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for OPZELURA Opzelura is a drug marketed by Incyte Corp and is included in one NDA. It is available from one supplier. There are ten patents…

The post New patent for Incyte Corp drug OPZELURA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.